Tubidy
    UROwebinar: Stone dust: What is it and how do lasers compare with each other?

    UROwebinar: Stone dust: What is it and how do lasers compare with each other?

    01:17:12 |
    Download MP3

    Related Videos

    UROwebinar: Everything you wanted to know about TURBT: How to handle peculiar situations in TURB 59:04

    UROwebinar: Everything you wanted to know about TURBT: How to handle peculiar situations in TURB

    UROwebinar: How to overcome individual challenges in contemporary BPO management 1:00:20

    UROwebinar: How to overcome individual challenges in contemporary BPO management

    Dr. Joan Palou about the European School of Urology (ESU) 3:13

    Dr. Joan Palou about the European School of Urology (ESU)

    UROwebinar: Handling adverse events after intravesical instillations in NMIBC 59:49

    UROwebinar: Handling adverse events after intravesical instillations in NMIBC

    Management of Paediatric Urolithiasis - European School of Urology 1:03:54

    Management of Paediatric Urolithiasis - European School of Urology

    UROwebinar: Basic principles of laparoscopy in paediatric urology 1:05:58

    UROwebinar: Basic principles of laparoscopy in paediatric urology

    UROwebinar: Administration of hormones in infertile males: Indications, EAU Guidelines, expectations 1:00:18

    UROwebinar: Administration of hormones in infertile males: Indications, EAU Guidelines, expectations

    UROwebinar: Partial nephrectomy: What's new about available approaches? 1:16:50

    UROwebinar: Partial nephrectomy: What's new about available approaches?

    UROwebinar: Stone dust: What is it and how do lasers compare with each other? 1:17:13

    UROwebinar: Stone dust: What is it and how do lasers compare with each other?

    UROwebinar: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancer 1:02:03

    UROwebinar: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancer

    UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST? 1:08:22

    UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST?

    UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy 1:01:24

    UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

    UROWebinar: How to get the best from your modern endourological armamentarium 56:54

    UROWebinar: How to get the best from your modern endourological armamentarium

    UROwebinar: Male infertility: An updated work-up 1:08:13

    UROwebinar: Male infertility: An updated work-up

    UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective 58:26

    UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

    UROWebinar: Update on novel imaging for non-invasive histological characterization of renal masses 1:01:59

    UROWebinar: Update on novel imaging for non-invasive histological characterization of renal masses

    UROwebinar: Update on the EAU ASCO testicular cancer guidelines 1:19:20

    UROwebinar: Update on the EAU ASCO testicular cancer guidelines

    UROwebinar: Metastatic prostate cancer 55:29

    UROwebinar: Metastatic prostate cancer

    UROWebinar: From molecular environment to theranostics in hormone sensitive prostate cance 1:09:59

    UROWebinar: From molecular environment to theranostics in hormone sensitive prostate cance

    UROWebinar: Male hypogonadism: Testosterone therapy is not dangerous 1:02:54

    UROWebinar: Male hypogonadism: Testosterone therapy is not dangerous